Globus Medical Schedules First Quarter Earnings Release and Conference Call
Globus Medical (NYSE:GMED), a leading musculoskeletal technology company, has scheduled its first quarter 2025 financial results announcement for Thursday, May 8, 2025, after market close. The company will host a conference call at 4:30 p.m. Eastern Time to discuss the Q1 performance ending March 31, 2025.
Investors can access the earnings release through the company's investor relations website at www.investors.globusmedical.com. The conference call will be available via:
- Webcast: Through the Investors page on Globus Medical's website
- Telephone: Participants must pre-register using the provided link to receive dial-in details, passcode, and registrant ID
An audio archive of the call will be made available on the company's investor website following the event.
Globus Medical (NYSE:GMED), un'azienda leader nel settore della tecnologia muscoloscheletrica, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per giovedì 8 maggio 2025, dopo la chiusura del mercato. La società terrà una conference call alle 16:30 ora della costa orientale per discutere le performance del primo trimestre terminato il 31 marzo 2025.
Gli investitori potranno consultare il comunicato sugli utili tramite il sito web dedicato agli investitori all'indirizzo www.investors.globusmedical.com. La conference call sarà accessibile tramite:
- Webcast: dalla pagina Investors sul sito di Globus Medical
- Telefono: i partecipanti devono registrarsi in anticipo tramite il link fornito per ricevere i dettagli di accesso, il codice di accesso e l'ID registrante
Un archivio audio della chiamata sarà disponibile sul sito degli investitori dopo l'evento.
Globus Medical (NYSE:GMED), una empresa líder en tecnología musculoesquelética, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el jueves 8 de mayo de 2025, después del cierre del mercado. La compañía realizará una llamada conferencia a las 4:30 p.m., hora del Este para analizar el desempeño del primer trimestre que terminó el 31 de marzo de 2025.
Los inversionistas podrán acceder al comunicado de resultados a través del sitio web de relaciones con inversionistas en www.investors.globusmedical.com. La llamada conferencia estará disponible por:
- Transmisión en vivo: a través de la página de Inversionistas en el sitio web de Globus Medical
- Teléfono: los participantes deben registrarse previamente usando el enlace proporcionado para recibir los detalles de acceso, código y ID de registro
Una grabación en audio de la llamada estará disponible en el sitio web de inversionistas después del evento.
Globus Medical (NYSE:GMED)은 근골격계 기술 분야의 선도 기업으로, 2025년 1분기 재무 실적 발표를 2025년 5월 8일 목요일 장 마감 후에 예정하고 있습니다. 회사는 2025년 3월 31일 종료된 1분기 실적에 대해 논의하기 위해 동부 표준시 오후 4시 30분에 컨퍼런스 콜을 진행할 예정입니다.
투자자들은 회사의 투자자 관계 웹사이트 www.investors.globusmedical.com을 통해 실적 발표 자료에 접근할 수 있습니다. 컨퍼런스 콜은 다음 경로로 참여할 수 있습니다:
- 웹캐스트: Globus Medical 웹사이트의 투자자 페이지를 통해
- 전화: 참가자는 제공된 링크를 통해 사전 등록해야 전화 접속 정보, 암호 및 등록자 ID를 받을 수 있습니다
행사 후 회사 투자자 웹사이트에서 통화 오디오 아카이브가 제공될 예정입니다.
Globus Medical (NYSE:GMED), une entreprise leader dans la technologie musculosquelettique, a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le jeudi 8 mai 2025, après la clôture du marché. La société tiendra une conférence téléphonique à 16h30, heure de l'Est pour discuter des performances du premier trimestre se terminant le 31 mars 2025.
Les investisseurs pourront consulter le communiqué des résultats sur le site des relations investisseurs de la société à l'adresse www.investors.globusmedical.com. La conférence téléphonique sera accessible via :
- Webcast : via la page Investisseurs du site de Globus Medical
- Téléphone : les participants doivent s'inscrire à l'avance via le lien fourni pour recevoir les détails d'accès, le code et l'identifiant d'inscription
Un enregistrement audio de l'appel sera disponible sur le site des investisseurs après l'événement.
Globus Medical (NYSE:GMED), ein führendes Unternehmen im Bereich der muskuloskelettalen Technologie, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für Donnerstag, den 8. Mai 2025, nach Börsenschluss geplant. Das Unternehmen wird um 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse des ersten Quartals, das am 31. März 2025 endete, zu besprechen.
Investoren können die Gewinnmitteilung über die Investor-Relations-Webseite des Unternehmens unter www.investors.globusmedical.com abrufen. Die Telefonkonferenz ist verfügbar über:
- Webcast: Über die Investors-Seite auf der Globus Medical Webseite
- Telefon: Teilnehmer müssen sich vorab über den bereitgestellten Link registrieren, um Einwahldaten, Zugangscode und Registranten-ID zu erhalten
Ein Audioarchiv des Anrufs wird nach der Veranstaltung auf der Investorenseite des Unternehmens bereitgestellt.
- None.
- None.
AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March 31, 2025 after the market close on Thursday, May 8, 2025. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.
Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call live via webcast on the Investors page of Globus Medical’s website at https://www.investors.globusmedical.com/news-events/events-webcasts.
To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
The audio archive will be available after the call on the Investors page of the Globus Medical website.
About Globus Medical, Inc.
Globus Medical, Inc. is a leading global musculoskeletal company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. Additional information can be accessed at www.globusmedical.com.
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, the risks and costs associated with the integration of the Nevro business, trends in the medical industry and the ability of Globus Medical and Nevro to: (i) successfully integrate and achieve anticipated synergies, (ii) manage our growth, (iii) sustain profitability, (iv) sustain demand for products, (v) compete successfully (including without limitation success in convincing surgeons to use Globus Medical or Nevro products and the ability to attract and retain sales and other personnel), (vi) rapidly develop and introduce new products, (vii) develop and execute successful business strategies, (viii) comply with changes and applicable laws and regulations that are or may become applicable to Globus Medical and/or Nevro, (ix) safeguard our intellectual property, and (x) succeed in defending against legal proceedings in addition to general economic conditions and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, refer to the disclosure of each of Globus Medical and Nevro contained in each company’s most recent annual report on Form 10-K filed with the U.S. Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in each company’s Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, both Globus Medical and Nevro operate in an evolving environment. New risk factors and uncertainties emerge from time to time, and it is not possible for Globus Medical and Nevro to predict all risk factors and uncertainties, nor can we assess the impact of all factors on the Globus Medical business and Nevro business, respectively, or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. Globus Medical and Nevro undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.
Contacts:
Investors:
Brian Kearns
Senior Vice President, Corporate Development and Investor Relations
(610) 930-1800
investors@globusmedical.com
www.globusmedical.com
Media:
Moran Chavez
Senior Director, Corporate Affairs
(619) 318-7681
media@globusmedical.com
FAQ
When will Globus Medical (GMED) release Q1 2025 earnings?
How can investors join the GMED Q1 2025 earnings call?
What period does Globus Medical's Q1 2025 earnings report cover?
What time is Globus Medical's Q1 2025 earnings conference call?
Where can I find GMED's Q1 2025 earnings release after publication?
